Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment

BMC Infectious Diseases

Table 3 Risk factors for carriage of resistant Escherichia coli ^a among women with UTI symptoms (n = 176)

Variable	Crude OR (95% CI)	Adjusted^b OR (95% CI)
Age (per year)	1.00 (0.98–1.02)	0.99 (0.97–1.01)
Incontinence	1.00 (0.99–1.02)	0.83 (0.39–1.80)
Diabetes	7.60 (0.67–86.26)	2.32 (0.13–39.77)
Abroad last 6 months	1.64 (0.66–4.10)	4.02 (1.35–11.95)
Treatment with UTI antibiotics within the last 12 months^c	3.83 (1.72–8.54)	4.97 (2.04–12.06)

^aGrowth of E.coli resistant to either mecillinam, trimethoprim, ciprofloxacin, cefadroxil or ESBL producing
^bMethod: Log regression, enter, adjusted for; age, incontinence, diabetes, abroad last 6 months and treatment with UTI antibiotics within the last 12 months
^cAntibiotic treatment reported by the patients

ISSN: 1471-2334